All entries on Recordati across all areas, newest first. tag:eurotrack.ai,2026:en:en/companies/recordati 2026-09-17T06:00:00Z Eurotrack tag:eurotrack.ai,2026:dd829efe:en 2026-09-17T06:00:00Z

Recordati has opened a collective redundancy procedure at its Campoverde active-ingredient plant in Aprilia (Latina province) covering 55 of its 301 permanent staff, 7 white-collar and 48 blue-collar. The group cites smaller batch sizes for its in-house drug products, Chinese and Indian competition and a planned volume drop of about 21% (roughly 120 tonnes) in 2027–29; production is to be concentrated on fewer lines and department 337 closed. It rules out short-time work and solidarity contracts, and talks with the unions are under way at Unindustria in Latina (Latina Oggi, 17.09.2026). — Source: https://www.latinaoggi.eu/news/attualita/322417/recordati-al-via-la-procedura-di-licenziamento-collettivo-a-campoverde-55-esuberi.html

tag:eurotrack.ai,2026:6a833e13:en 2026-05-22T06:00:00Z

CVC, already holding 46.8% of Recordati, has made a binding cash offer of €51.29 per share, about €10.7bn, together with GBL, ADIA unit Luxinva, Canadian pension fund CPPIB and chairman Andrea Recordati, aiming to delist the company; CVC had made a non-binding approach in March (pharmaphorum, 22 May 2026). Update (6 October 2026): the bidders raised the offer to €53 per share (Il Sole 24 Ore, 6 October 2026). — Sources: https://pharmaphorum.com/news/gbl-joins-cvc-eu107bn-takeover-bid-recordati · https://en.ilsole24ore.com/art/cvc-and-gbl-raise-their-bid-for-recordati-to-53-euros-per-share-AJbA2caB